We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-23.43%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$399M
AUM Growth
-$460M
Cap. Flow
-$276M
Cap. Flow %
-69.13%
Top 10 Hldgs %
19.48%
Holding
1,817
New
428
Increased
261
Reduced
305
Closed
820

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$8.95M
2
FCX icon
Freeport-McMoran
FCX
+$6.66M
3
NVDA icon
NVIDIA
NVDA
+$3.85M
4
AAPL icon
Apple
AAPL
+$3.32M
5
PRAH
PRA Health Sciences, Inc.
PRAH
+$3.12M

Sector Composition

Rank Sector Weight
1 Technology 14.05%
2 Consumer Discretionary 11.17%
3 Healthcare 11.12%
4 Financials 10.47%
5 Industrials 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVTA
1676
DELISTED
Avantax, Inc. Common Stock
AVTA
-26,480
Closed -$692K
CCF
1677
DELISTED
Chase Corporation
CCF
-2,599
Closed -$308K
CEQP
1678
DELISTED
Crestwood Equity Partners LP
CEQP
-21,939
Closed -$676K
ZYNE
1679
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-22,106
Closed -$134K
SYNH
1680
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-23,907
Closed -$1.42M
MMP
1681
DELISTED
Magellan Midstream Partners, L.P.
MMP
-7,525
Closed -$473K
WWE
1682
DELISTED
World Wrestling Entertainment
WWE
-15,749
Closed -$1.02M
BKI
1683
DELISTED
Black Knight, Inc. Common Stock
BKI
-4,673
Closed -$301K
KDNY
1684
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-11,769
Closed -$69K
SPPI
1685
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-23,345
Closed -$85K
ATTO
1686
DELISTED
Atento S.A.
ATTO
-4,317
Closed -$62K
DBD
1687
DELISTED
Diebold Nixdorf Incorporated
DBD
-13,609
Closed -$144K
BLCM
1688
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-6,647
Closed -$86K
MNTV
1689
DELISTED
Momentive Global Inc. Common Stock
MNTV
-66,035
Closed -$1.18M
AQUA
1690
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
-23,339
Closed -$442K
IAA
1691
DELISTED
IAA, Inc. Common Stock
IAA
-4,522
Closed -$213K
CNCE
1692
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-48,565
Closed -$448K
ELVT
1693
DELISTED
Elevate Credit, Inc.
ELVT
-15,900
Closed -$71K
LHCG
1694
DELISTED
LHC Group LLC
LHCG
-3,020
Closed -$416K
SJI
1695
DELISTED
South Jersey Industries, Inc.
SJI
-9,131
Closed -$301K
VIVO
1696
DELISTED
Meridian Bioscience Inc
VIVO
-40,794
Closed -$399K
SWCH
1697
DELISTED
Switch, Inc. Class A Common Stock
SWCH
-35,561
Closed -$527K
TEN
1698
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
-68,535
Closed -$898K
ZVO
1699
DELISTED
Zovio Inc. Common Stock
ZVO
-12,696
Closed -$26K
AVLR
1700
DELISTED
Avalara, Inc.
AVLR
-4,553
Closed -$334K

Similar funds

GSA Capital Partners's Q1 2020 Portfolio in Review

As of Q1 2020, GSA Capital Partners held 1,817 positions worth $399M, down 54% from $859M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

GSA Capital Partners withdrew a net $276M in Q1 2020, closing 820 positions and reducing 305 holdings. Its most notable exit was Freeport-McMoran, an estimated $6.66M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, GSA Capital Partners opened a new position in State Street SPDR Bloomberg High Yield Bond ETF worth $34.1M.

  • GSA Capital Partners's largest Q1 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 360,000 shares worth $34.1M.
  • GSA Capital Partners added most to Carnival Corporation Ltd in Q1 2020, an estimated $3.06M increase.
  • GSA Capital Partners's biggest Q1 2020 reduction was Alibaba, cutting an estimated $8.95M.
  • GSA Capital Partners fully exited Freeport-McMoran in Q1 2020, selling an estimated $6.66M.
  • GSA Capital Partners's ten largest holdings make up 19% of its $399M portfolio in Q1 2020.
  • GSA Capital Partners opened 428 new positions and closed 820 in Q1 2020.
  • GSA Capital Partners's portfolio value fell 54% quarter-over-quarter to $399M.

Based on GSA Capital Partners's 13F filing for Q1 2020, filed 12 May 2020.